comparemela.com

Aptuit Verona News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OCTP cannabinoid receptor given approval for trial

A cannabinoid receptor, that has shown potential as an effective treatment for chemotherapy induced peripheral neuropathy (CIPN) has been given approval for a phase 1 clinical trial by the Medicines and Healthcare Products Regulatory Agency (MRHA) and The Wales Research Ethics Committee 2 (REC 2).

Oxford Cannabinoid Technologies Holdings PLC submits milestone application for Phase I trial for lead programme

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) (OCTP) said it has submitted a Phase 1 trial application for its lead programme.

Oxford Cannabinoid Technologies: Clinical objectives confirmed for 2023

Oxford Cannabinoid Technologies: Clinical objectives confirmed for 2023 Pharmaceuticals derived from cannabinoids Oxford Cannabinoid Technologies (OCT).

Oxford Cannabinoid Technologies Holdings PLC issues positive trading and operational update

Oxford Cannabinoid Technologies Holdings PLC issues positive trading and operational update
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.